Other Federal Projects in Genomics
The Cancer Genome Anatomy Project (CGAP)
The goal of the NCI's Cancer Genome Anatomy Project is to determine the gene expression profiles of normal, precancer, and cancer cells, leading eventually to improved detection, diagnosis, and treatment for the patient. By collaborating with scientists worldwide, CGAP seeks to increase its scientific expertise and expand its databases for the benefit of all cancer researchers.
The Cancer Genome Atlas (TCGA)
The Cancer Genome Atlas (TCGA) is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing.
Centers for Disease Control and Prevention (CDC)
The Office of Genomics and Disease Prevention integrates advances in human genetics into public health research, policies, and programs. The OGDP participates in national policy-setting panels, supports extramural population-based research projects, and educates and trains health professionals about the role of genetics in disease prevention.
The Department of Energy (DOE)
The DOE Human Genome Program supports research projects at universities, the DOE Joint Genome Institute, DOE-owned national laboratories, and other research organizations. As part of the international Human Genome Project, vital and very active genome research also is being pursued by researchers and science funding agencies outside the United States.
Food and Drug Administration (FDA)
The Food and Drug Administration (FDA) promotes and protects the public health by helping safe and effective products reach the market in a timely way, and monitoring products for continued safety after they are in use. The FDA blends law and science with the aim of protecting consumers. As knowledge gained from genomic and genetic research leads to the development of new and more specific medications for a wide range of disease, the FDA will continue to monitor and regulate these new therapies to protect consumers.
The Genetic Association Information Network (GAIN)
The Genetic Association Information Network (GAIN) is a public-private partnership of the Foundation for the National Institutes of Health, Inc. (FNIH) and includes partnerships with the National Institutes of Health (NIH) and the private sector.
The Genes and Environment Initiative (GEI)
The Genes, Environment and Health Initiative (GEI) will support research leading to the understanding of genetic contributions and gene-environment interactions in common disease. GEI is being developed and planned by an NIH-wide Coordinating Committee, administratively led by the National Human Genome Research Institute (NHGRI) and the National Institute of Environmental Health Sciences (NIEHS).
Health Resources and Services Administration (HRSA)
The Health Reources and Services Administration (HRSA) works to to improve and expand access to quality health care for all and assure the availability of quality health care to low income, uninsured, isolated, vulnerable and special needs populations. In the area of genetics and genomics, HRSA funds education and training programs for medical professionals, developing and expanding their genetic and genomic knowledge base related to specific disease processes encountered in the clinical setting.
National Science Foundation Plant Genome Research Program (NSF)
The National Science Foundation (NSF) Plant Genome Research Program was initiated in 1998. It is part of a national plant genome research initiative established by the Office of Science and Technology Policy. The long-term goal of this program is to understand the structure, organization and function of plant genomes important to agriculture, the environment, energy and health.
United States Department of Agriculture (USDA)
The USDA's Plant Genome Research Program, established in 2001 will facilitate the improvement of plants - agronomic, horticultural, and forest species - by locating important genes and markers on chromosomes, determining the structure of those genes, and transferring the genes to improve performance. The end product will be superior plant varieties that more closely meet marketplace needs and niches, while creating a positive effect on the environment.
Last Updated: August 18, 2008